Pilot Evaluation of Smart vs HERO Broadband Light Treatment for Pigmented Skin Lesions
NCT04936919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2023-04-19
Summary
The purpose of the study is to investigate the effects of Intense Pulsed Broad Band Light for treatment of pigmented lesions
Conditions
- Pigmented Lesions
Interventions
- DEVICE
-
BroadBand Light
Treatment arm will receive Broadband light treatment
Sponsors & Collaborators
-
Sciton
lead INDUSTRY
Principal Investigators
-
Swengel, MD · RefinedMD
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-28
- Primary Completion
- 2022-02-25
- Completion
- 2022-03-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions
NCT04493021 ·Status: COMPLETED ·Phase: NA
-
Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions
NCT03944278 ·Status: COMPLETED ·Phase: NA
-
Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI
NCT05493280 ·Status: COMPLETED ·Phase: NA
-
The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients
NCT03718962 ·Status: COMPLETED ·Phase: NA
-
Study of Light Treatment and Laser Treatment for Melasma
NCT00509977 ·Status: COMPLETED ·Phase: NA
-
Fractionated 1927-nm Non Ablative Thulium Laser in Treating Post Inflammatory Hyperpigmentation
NCT06149780 ·Status: RECRUITING ·Phase: NA
-
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
NCT00785369 ·Status: COMPLETED ·Phase: NA
-
Fractionated 1927nm Laser for Diffuse Pigmentation and Actinic Changes.
NCT05226104 ·Status: COMPLETED ·Phase: NA
-
Comparison of Picosecond and Q-switched Laser for Benign Pigmented Lesions Treatment
NCT02800525 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions
NCT03565146 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Evaluate the Interest of PDL in the Management of Telangiectasia of the Face and Neckline in Systemic Scleroderma
NCT05036200 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of STBF Photodynamic Therapy for Moderate and Severe Acne Vulgaris
NCT05245045 ·Status: UNKNOWN ·Phase: NA
-
Comparison of the Efficacy of Micro-holes vs. Laser-assisted Dermabrasion, for Repigmenting in Vitiligo Skin
NCT02660320 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the 755nm Alexandrite for the Treatment of Epidermal and Dermal Pigmented Lesions
NCT01754233 ·Status: COMPLETED ·Phase: NA
-
Combined Therapy of Photoelectric Instruments and Human Umbilical Cord Mesenchymal Stem Cells for Pigmentary Disorders
NCT06911281 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241 ·Status: COMPLETED ·Phase: NA
-
Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions
NCT04203745 ·Status: COMPLETED ·Phase: NA
-
A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma
NCT03049059 ·Status: COMPLETED ·Phase: PHASE2
-
Advanced Harmonic Generation Microscopy for Treatment Assessment of Cutaneous Pigmentary Disorder
NCT03578315 ·Status: COMPLETED ·Phase: NA
-
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
NCT01529996 ·Status: COMPLETED ·Phase: NA
-
Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte
NCT01491620 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
NCT03076918 ·Status: COMPLETED ·Phase: NA
-
Dermatosis Papulosa Nigra
NCT00710203 ·Status: COMPLETED ·Phase: NA
-
Improved Phototherapy in Patients With Vitiligo
NCT05836441 ·Status: UNKNOWN ·Phase: NA
-
Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna
NCT00707174 ·Status: COMPLETED ·Phase: NA